Full Text View
Tabular View
No Study Results Posted
Related Studies
The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2007 by Hackensack University Medical Center.   Recruitment status was  Recruiting

First Received on May 30, 2007.   No Changes Posted
Sponsor: Hackensack University Medical Center
Information provided by: Hackensack University Medical Center
ClinicalTrials.gov Identifier: NCT00481585
  Purpose

The objective of the present study is to determine whether or not primary human mammary epithelial cells are competent for use in molecular studies of transepithelial electrophysiology focusing on the function of the tight junction protein claudin 3.

Human breast Tissue will be removed from mastectomy specimens and used as a source to generate epithelial cells for study.


Condition
Breast Cancer

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture

Resource links provided by NLM:


Further study details as provided by Hackensack University Medical Center:

Estimated Enrollment: 20
Study Start Date: May 2007
  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Subjects of this pilot study are limited to those female patients who are undergoing therapeutic or prophylactic mastectomy procedures conducted by the department of Surgery at HUMC.

Exclusion Criteria:

  • From within this population, no exclusion criteria shall be applied based on age, race, ethnicity, gender, HIV status, or menopause.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00481585

Locations
United States, New Jersey
Hackensack Univeristy Medical Center Recruiting
Hackensack, New Jersey, United States, 07601
Contact: William C. Black, M.D.     201-336-2794     wblack@humed.com    
Principal Investigator: Erik F. Young, Ph.D.            
Sub-Investigator: Richard J Davies, M.D.            
Sponsors and Collaborators
Hackensack University Medical Center
Investigators
Principal Investigator: Erik F Young, Ph.D. Hackensack University Medical Center
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00481585     History of Changes
Other Study ID Numbers: 07.01.041
Study First Received: May 30, 2007
Last Updated: May 30, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by Hackensack University Medical Center:
claudin
electrophysiology
breast
screening

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on February 09, 2012